| 1 | 2660797 | Temozolomide induced differentiation of K562 leukemia cells is not mediated by gene hypomethylation. | Biochem Pharmacol | 1989 Jul 1 |
1 |
| 2 | 7547230 | Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors. | Br J Cancer | 1995 Oct |
1 |
| 3 | 7640049 | Temozolomide reduces the metastatic potential of Lewis lung carcinoma (3LL) in mice: role of alpha-6 integrin phosphorylation. | Eur J Cancer | 1995 |
2 |
| 4 | 8612308 | Intracellular Localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase. | Cancer Chemother Pharmacol | 1996 |
1 |
| 5 | 8645346 | Retrovirus-mediated transfer of the human O6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents. | Biochem Pharmacol | 1996 May 3 |
1 |
| 6 | 8855970 | 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity. | Br J Cancer | 1996 Oct |
1 |
| 7 | 9271347 | Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide. | Mol Pharmacol | 1997 Aug |
2 |
| 8 | 9580640 | Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase. | J Pharmacol Exp Ther | 1998 May |
3 |
| 9 | 9747464 | Chemoprotective gene transfer I: transduction of human haemopoietic progenitors with O6-benzylguanine-resistant O6-alkylguanine-DNA alkyltransferase attenuates the toxic effects of O6-alkylating agents in vitro. | Gene Ther | 1998 Jun |
1 |
| 10 | 9816224 | Role of O6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin. | Clin Cancer Res | 1996 Apr |
1 |
| 11 | 9820180 | O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. | Br J Cancer | 1998 Nov |
2 |
| 12 | 9918549 | Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines. | J Pharmacol Exp Ther | 1999 Feb |
3 |
| 13 | 10097137 | Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. | Proc Natl Acad Sci U S A | 1999 Mar 30 |
1 |
| 14 | 10360379 | Treatment with temozolomide and poly(ADP-ribose) polymerase inhibitors induces early apoptosis and increases base excision repair gene transcripts in leukemic cells resistant to triazene compounds. | Leukemia | 1999 Jun |
4 |
| 15 | 10375003 | DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents. | Mutagenesis | 1999 May |
1 |
| 16 | 10537360 | Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents. | Clin Cancer Res | 1999 Oct |
4 |
| 17 | 10565854 | O(6)-benzylguanine enhances the in vitro immunotoxic activity of temozolomide on natural or antigen-dependent immunity. | J Pharmacol Exp Ther | 1999 Dec |
1 |
| 18 | 10584923 | Characterization of the P140K, PVP(138-140)MLK, and G156A O6-methylguanine-DNA methyltransferase mutants: implications for drug resistance gene therapy. | Hum Gene Ther | 1999 Nov 20 |
2 |
| 19 | 10741722 | Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells. | Clin Cancer Res | 2000 Mar |
1 |
| 20 | 10741727 | Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models. | Clin Cancer Res | 2000 Mar |
2 |
| 21 | 10791902 | Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction. | J Hematother Stem Cell Res | 1999 Oct |
4 |
| 22 | 10900246 | Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells. | J Pharmacol Exp Ther | 2000 Aug |
8 |
| 23 | 11054678 | O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study. | Int J Cancer | 2000 Nov 1 |
4 |
| 24 | 11138465 | Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen. | Cancer Chemother Pharmacol | 2000 |
1 |
| 25 | 11162314 | Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector. | Mol Ther | 2001 Jan |
1 |
| 26 | 11280752 | p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. | Cancer Res | 2001 Mar 1 |
8 |
| 27 | 11302252 | A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study. | Neuro Oncol | 2000 Jan |
2 |
| 28 | 11345654 | Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components. | Cancer Chemother Pharmacol | 2001 Apr |
1 |
| 29 | 11350911 | Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents. | Clin Cancer Res | 2001 May |
2 |
| 30 | 11351250 | Heterogeneous methylation of the O(6)-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines. | Int J Oncol | 2001 Jun |
3 |
| 31 | 11416201 | Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide. | Proc Natl Acad Sci U S A | 2001 Jun 19 |
2 |
| 32 | 11423906 | Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells. | Cell Death Differ | 2001 May |
6 |
| 33 | 11445852 | Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU. | Int J Oncol | 2001 Aug |
1 |
| 34 | 11454697 | Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. | Cancer Res | 2001 Jul 15 |
2 |
| 35 | 11470740 | hMSH3 overexpression and cellular response to cytotoxic anticancer agents. | Carcinogenesis | 2001 Aug |
1 |
| 36 | 11479224 | Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. | Cancer Res | 2001 Aug 1 |
17 |
| 37 | 11553261 | Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones. | Eur J Haematol | 2001 Jul |
1 |
| 38 | 11912174 | Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase. | Cancer Res | 2002 Mar 15 |
5 |
| 39 | 12171906 | Multifaceted resistance of gliomas to temozolomide. | Clin Cancer Res | 2002 Aug |
10 |
| 40 | 12231548 | The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress. | Clin Cancer Res | 2002 Sep |
2 |
| 41 | 12237842 | Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells. | Glia | 2002 Oct |
2 |
| 42 | 12650433 | Delayed repletion of O6-methylguanine-DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity. | J Neurosurg | 2003 Mar |
15 |
| 43 | 12673724 | Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. | Cancer | 2003 Apr 15 |
2 |
| 44 | 12684420 | O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. | Clin Cancer Res | 2003 Apr |
1 |
| 45 | 12730104 | Repopulating defect of mismatch repair-deficient hematopoietic stem cells. | Blood | 2003 Sep 1 |
1 |
| 46 | 12797396 | DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system. | J Chemother | 2003 Apr |
1 |
| 47 | 12800606 | Phase I. Trial of irinotecan and temozolomide in patients with solid tumors. | Oncology (Williston Park) | 2003 May |
1 |
| 48 | 12815001 | Formation of DNA adducts and induction of lacI mutations in Big Blue Rat-2 cells treated with temozolomide: implications for the treatment of low-grade adult and pediatric brain tumors. | Cancer Epidemiol Biomarkers Prev | 2003 Jun |
4 |
| 49 | 12855651 | Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies. | Clin Cancer Res | 2003 Jul |
1 |
| 50 | 12967659 | Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo. | DNA Repair (Amst) | 2003 Sep 18 |
4 |